Low potassium level during the first half of pregnancy is associated with lower risk for the development of gestational diabetes mellitus and severe pre-eclampsia

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 23, Issue 9, 2010, Pages 994-998

  Wolak, Talya ^a   Sergienko, Ruslan ^b   Wiznitzer, Arnon ^a   Ben Shlush, Lior ^b   Paran, Esther ^a   Sheiner, Eyal ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

gestational diabetes mellitus; Potassium; severe pre eclampsia

Indexed keywords

POTASSIUM;

ADULT; ARTICLE; BIRTH WEIGHT; CHILDBIRTH; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; HYPERKALEMIA; HYPOKALEMIA; MAJOR CLINICAL STUDY; MATERNAL AGE; PARITY; POTASSIUM BLOOD LEVEL; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY;

ADULT; DIABETES, GESTATIONAL; FEMALE; GESTATIONAL AGE; HUMANS; HYPERTENSION; POTASSIUM; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 77955904381     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767050903544736     Document Type: Article

References (26)

1. Pouta A, Hartikainen AL, Sovio U, Gissler M, Laitinen J, McCarthy MI, Ruokonen A, Elliott P, Jarvelin MR. Manifestations of metabolic syndrome after hypertensive pregnancy. Hypertension 2004;43:825-831.
2. Callaway LK, Lawlor DA, O'Callaghan M, Williams GM, Najman JM, McIntyre HD. Diabetes mellitus in the 21 years after a pregnancy that was complicated by hypertension: findings from a prospective cohort study. Am J Obstet Gynecol 2007;197:492 e1-e7.
3. Stella CL, O'Brien JM, Forrester KJ, Barton JR, Istwan N, Rhea D, Sibai BM. The coexistence of gestational hypertension and diabetes: influence on pregnancy outcome. Am J Perinatol 2008;25:325-329.
4. Eriksson JW, Jansson PA, Carlberg B, Hagg A, Kurland L, Svensson MK, Ahlstrom H, Strom C, Lonn L, Ojbrandt K, Johansson L, Lind L. Hydrochlorothiazide, but not Candesartan, aggravates insulin resistance and causes visceral and hepatic fat accumulation: the mechanisms for the diabetes preventing effect of Candesartan (MEDICA) Study. Hypertension 2008;52:1030-1037.
5. Gorden P. Glucose intolerance with hypokalemia. Failure of short-term potassium depletion in normal subjects to reproduce the glucose and insulin abnormalities of clinical hypokalemia. Diabetes 1973;22:544-551.
6. Plavinik FL, Rodrigues CI, Zanella MT, Ribeiro AB. Hypokalemia, glucose intolerance, and hyperinsulinemia during diuretic therapy. Hypertension 1992;19(2 Suppl):II26-II29.
7. Couette B, Lombes M, Baulieu EE, Rafestin-Oblin ME. Aldosterone antagonists destabilize the mineralocorticosteroid receptor. Biochem J 1992;282 (Pt 3):697-702.
8. Lindheimer MD, Richardson DA, Ehrlich EN, Katz AI. Potassium homeostasis in pregnancy. J Reprod Med 1987;32:517-522.
9. Jovanovic L. American Diabetes Association's Fourth International Workshop-Conference on Gestational Diabetes Mellitus: summary and discussion. Therapeutic interventions. Diabetes Care 1998;21(Suppl 2):B131-B137.
10. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol 2002;99:159-167
11. Agresti A. Introduction to categorical data analysis. In: NY: John Wiley and Sons; 1996.
12. Zillich AJ, Garg J, Basu S, Bakris GL, Carter BL. Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. Hypertension 2006;48:219-224.
13. Krishna GG. Effect of potassium intake on blood pressure. J Am Soc Nephrol 1990;1:43-52.
14. Tranquilli AL, La Palombara C, Rabini RA, Leocani B, Testa I, Romanini C. Intracellular potassium in normal and pathological pregnancy. II. Experimental results. Ann Ostet Ginecol Med Perinat 1989;110:229-235.
15. Tranquilli AL, Bilancia F, Valensise H, Garzetti GG, Romanini C. Intracellular potassium in normal and pathological pregnancy. I. Regulation of transport and concentration. Ann Ostet Ginecol Med Perinat 1989;110:226-228.
16. Wolf M, Sandler L, Munoz K, Hsu K, Ecker JL, Thadhani R. First trimester insulin resistance and subsequent preeclampsia: a prospective study. J Clin Endocrinol Metab 2002;87: 1563-1568.
17. Parsons JA, Brelje TC, Sorenson RL. Adaptation of islets of Langerhans to pregnancy: increased islet cell proliferation and insulin secretion correlates with the onset of placental lactogen secretion. Endocrinology 1992;130:1459-1466.
18. Buchanan TA, Xiang AH. Gestational diabetes mellitus. J Clin Invest 2005;115:485-491.
19. DeFronzo RA, Felig P, Ferrannini E, Wahren J. Effect of graded doses of insulin on splanchnic and peripheral potassium metabolism in man. Am J Physiol 1980;238:E421-E427.
20. Lain KY, Roberts JM. Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA 2002;287: 3183-3186.
21. Wilson BJ, Watson MS, Prescott GJ, Sunderland S, Campbell DM, Hannaford P, Smith WC. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ 2003;326:845.
22. Greenlee M, Wingo CS, McDonough AA, Youn JH, Kone BC. Narrative review: evolving concepts in potassium homeostasis and hypokalemia. Ann Intern Med 2009;150: 619-625.
23. Godard C, Gaillard R, Vallotton MB. The renin-angiotensinaldosterone system in mother and fetus at term. Nephron 1976;17:353-360.
24. Quinkler M, Meyer B, Bumke-Vogt C, Grossmann C, Gruber U, Oelkers W, Diederich S, Bahr V. Agonistic and antagonistic properties of progesterone metabolites at the human mineralocorticoid receptor. Eur J Endocrinol 2002;146:789-799.
25. Davison JM, Dunlop W. Renal hemodynamics and tubular function normalhumanpregnancy. Kidney Int 1980;18:152-161.
26. Karumanchi SA, Maynard SE, Stillman IE, Epstein FH, Sukhatme VP. Preeclampsia: a renal perspective. Kidney Int 2005;67:2101-2113.